Sharpe Jeffrey Nathan
Sharpe Jeffrey Nathan, DIR, reported a transaction classified as exercise at Conexeu Sciences Inc. involving 500000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 1000000.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- May 22, 2026
- Filing date
- May 26, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
CNXU price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001062993-26-002870 Performance Warrants
- Transaction date
- May 22, 2026 Filed May 26, 2026, 10:16 AM · 4d delay
- Shares
- 500,000 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 1,000,000 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-10 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
- F1
The transaction is also exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act.
- F2
The Performance Warrants were granted on June 5, 2025 and have an exercise price of $0.001 and a term of 5 years. The Performance Warrants were granted for services rendered to the issuer and no price…
0 other transactions
0 recent txs